Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitorsSUN, Jong-Mu; AHN, Myung-Ju; CHOI, Yoon-La et al.Lung cancer. 2013, Vol 82, Num 2, pp 294-298, issn 0169-5002, 5 p.Article

The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancerYOUNG SAING KIM; SUN, Jong-Mu; JIN SEOK AHN et al.Lung cancer. 2013, Vol 81, Num 2, pp 231-235, issn 0169-5002, 5 p.Article

Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 yearsJI HYE MIN; HO YUN LEE; KYUNG SOO LEE et al.Lung cancer. 2010, Vol 69, Num 1, pp 123-126, issn 0169-5002, 4 p.Article

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancerMYUNG HEE CHANG; JEEYUN LEE; JOUNGHO HAN et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2009, Vol 117, Num 12, pp 861-869, issn 0903-4641, 9 p.Article

Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapyCHOI, Byung-Ryul; AHN, Myung-Ju; WOONG SOO LEE et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 4, pp 311-313, issn 0172-8172, 3 p.Article

Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage TreatmentSEUNG TAE KIM; LEE, Jeeyun; SUN, Jong-Mu et al.Oncology. 2010, Vol 79, Num 1-2, pp 78-84, issn 0030-2414, 7 p.Article

A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): Paclitaxel plus carboplatin versus vinorelbine plus cisplatinWON JIN CHANG; SUN, Jong-Mu; JI YEAN LEE et al.Lung cancer. 2014, Vol 84, Num 1, pp 51-55, issn 0169-5002, 5 p.Article

Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insightJI HYE MIN; HO YUN LEE; LIM, Hoyeong et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1099-1109, issn 0344-5704, 11 p.Article

Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsSUN, Jong-Mu; MI HYUN NAM; JAE YONG CHUNG et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 531-538, issn 0344-5704, 8 p.Article

Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsSUN, Jong-Mu; AHN, Myung-Ju; MIN JAE PARK et al.Lung cancer. 2010, Vol 69, Num 1, pp 105-109, issn 0169-5002, 5 p.Article

Metabolic Tumor Volume of [¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal CancerMAN KI CHUNG; JEONG, Han-Sin; KIM, Hyung-Jin et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5861-5868, issn 1078-0432, 8 p.Article

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trialAHN, Myung-Ju; CHOI, Jung-Hye; JUNG, Cheol-Won et al.International journal of hematology. 2003, Vol 78, Num 2, pp 133-138, issn 0925-5710, 6 p.Article

Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarrayCHOI, Jung-Hye; AHN, Myung-Ju; PARK, Chan-Kum et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2006, Vol 114, Num 9, pp 619-625, issn 0903-4641, 7 p.Article

Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinomaSUN, Jong-Mu; LIRA, Maruja; PANDYA, Kinnari et al.Lung cancer. 2014, Vol 83, Num 2, pp 259-264, issn 0169-5002, 6 p.Article

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?JI YUN LEE; SUNG HEE LIM; JIN SEOK AHN et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1063-1070, issn 0344-5704, 8 p.Article

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non―Small-Cell Lung Cancer: AVAPERL (MO22089)BARLESI, Fabrice; SCHERPEREEL, Arnaud; WONG, Elaine K et al.Journal of clinical oncology. 2013, Vol 31, Num 24, pp 3004-3011, issn 0732-183X, 8 p.Article

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?KYOUNG HA KIM; LEE, Jeeyun; SEONG YOON YI et al.Lung cancer. 2010, Vol 68, Num 2, pp 258-263, issn 0169-5002, 6 p.Article

Multicenter Phase 2 Study of Belotecan, a New Camptothecin Analog, and Cisplatin for Chemotherapy-Naive Patients With Extensive-Disease Small Cell Lung CancerDAE HO LEE; KIM, Sang-We; SUNG HYUN YANG et al.Cancer. 2010, Vol 116, Num 1, pp 132-136, issn 0008-543X, 5 p.Article

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancerMYUNG HEE CHANG; JIN SEOK AHN; LEE, Jeeyun et al.Lung cancer. 2010, Vol 69, Num 3, pp 323-329, issn 0169-5002, 7 p.Article

Comparison of Survival in Advanced Non-Small Cell Lung Cancer Patients in the Pre-and Post-Gefitinib ErasHYO SONG KIM; PARK, Keunchil; HYUN JUNG JUN et al.Oncology. 2009, Vol 76, Num 4, pp 239-246, issn 0030-2414, 8 p.Article

L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumorsHYO SONG KIM; SEONG YOON YI; LI, Shengjin et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2009, Vol 117, Num 2, pp 140-146, issn 0903-4641, 7 p.Article

Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian PatientsYOUNGWOOK KIM; HAMMERMAN, Peter S; LAWRENCE, Michael S et al.Journal of clinical oncology. 2014, Vol 32, Num 2, pp 121-128, issn 0732-183X, 8 p.Article

A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)JUN HO JI; YUN, Tak; DEOK WON HWANG et al.European journal of cancer (1990). 2012, Vol 48, Num 17, pp 3198-3204, issn 0959-8049, 7 p.Article

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancerAHN, Myung-Ju; CHIH-HSIN YANG, James; JUN LIANG et al.Lung cancer. 2012, Vol 77, Num 2, pp 346-352, issn 0169-5002, 7 p.Article

Clinical Impact of Amphiregulin Expression in Patients With Epidermal Growth Factor Receptor (EGFR) Wild-Type Nonsmall Cell Lung Cancer Treated With EGFR-Tyrosine Kinase InhibitorsMYUNG HEE CHANG; HEE KYUNG AHN; LEE, Jeeyun et al.Cancer. 2011, Vol 117, Num 1, pp 143-151, issn 0008-543X, 9 p.Article